LY96 and neoplasm: LY96 expression was gradually upregulated from TNM I to TNM IV stages in BRCA, KIRC, KIRP, BLCA, UVM, MESO, STAD, and UVM, which indirectly explained the role of LY96 in tumor progression among these cancers.